Episodic Migraine Research Study – 3110

Do You Have Migraine?


Searching for individuals who
battle with Episodic Migraines!


A member of our staff will be in contact with you shortly.

How frequently do you experience migraine? If you struggle with Episodic Migraines (2-8 migraine attacks with moderate/severe headache per month) we want to chat!

Clinvest is investigating a new treatment option, but we need participation to explore new horizons in health. We are searching for Springfield area applicants to participate in a clinical research study to potentially improve options for individuals diagnosed with Episodic Migraine. The goal of this study is to assess an investigational medication for Migraine. If you believe you would make a good candidate, contact Clinvest Research for more information.

Dr. True and Clinvest are seeking volunteers with Prodrome prior to Episodic Migraines in the Springfield area. The overall study objective is to evaluate the efficacy, safety, and tolerability of ubrogepant 100mg compared to placebo for the acute treatment of migraine during prodrome. Participants will be randomized (1:1) to treatment sequences A or B in this crossover study. Completion of the study would involve coming into the office for 4 appointments and 1 phone call over approximately a 4-month period. Your first appointment would last approximately 2 hours. You will be asked to come into the office for 2 visits that will occur up to 60 days after initial screening. If you qualify and choose to volunteer, we would provide the study drug and all study-related procedures at no cost to you (including basic study-related physical exams, bloodwork, ECG’s, and urine drug/pregnancy tests). Compensation will be provided for your time and travel.



Clinvest Research is a clinical investigation company based in southwest Missouri. We are constantly seeking participants for clinical trials in order to further options for sufferers of various conditions. Our doctors are a part of a select group of clinics in the U.S. that have been involved in over 200 Phase II-IV clinical research studies sponsored primarily by the pharmaceutical industry or studies created by doctors after patient observation.

Study visits are conducted via outpatient and do not require overnight stays. In fact, we pride ourselves in making your participation in the studies as easy and convenient as possible.

If you qualify and choose to join a study, you will be treated by our team of specialists and may receive study-related care at no cost. Call us at (417) 883-7889 to learn more.